-
Nobel Laureate Amartya Sen notes on Ayushman Bharat Yojana
Money could have been better spent on medical infrastructure, Sen says Economist Amartya Sen on Friday criticised the Centre’s Ayushman Bharat Yojana, saying it does not fulfil the requirements of primary healthcare and that the money could have been used better by improving medical infrastructure. “If we look at the healthcare system, we will see…
-
Defining Biosimilars in Oncology: Priyanka Singh Pharma Entrepreneur
“We are totally committed to improving the safety and wellbeing of all people who work with us, or come into contact with our operations and products”! WHAT IS Biosimilars: Unlike generic chemical medicines where the active ingredients are identical, biosimilars – by definition – are not likely to be identical to the originator biologic. They…
-
K. Parasaran an Indian Lawyer : SabArimala Temple Case: Pitamaha of Indian Bar
Shri. Parasaran today is one of the legal luminaries of India having a successful legal career for over 6 decades. Brief Biography : K. Parasaran (born 9 October 1927) is an Indian lawyer. He was Advocate-General of Tamil Nadu during President’s rule in 1976 and then, Attorney General of India under Indira Gandhi and Rajiv…
-
Nani Palkhivala The Legendary Indian Lawyer and Economist
Author of ‘We the Nation’ Nanaboy “Nani” Ardeshir Palkhivala Born in Mumbai, India January 16, 1920 Died December- 11, 2002 was an Indian jurist and economist Books Authored: 1.Law and Practice of Income tax 2.Taxation in India 3.The Highest Taxed Nation 4.Judiciary Made to Measure 5.Our Constitution Defaced and Defiled 6.India’s Priceless Heritage 7.Essential Unity of all Religions 8.We, the people 9.…
-
Taj Pharma healthcare mission in Russia and CIS countries by 2020
ТАДЖ ФАРМА medicines are dedicated to treat complex health conditions such as renal insufficiency, Cancer, Hepatitis C and HIV infections and other disorders. TAJ PHARMA CIS (ТАДЖ ФАРМА) is Russia’s leading innovative Generics and branded Pharmaceuticals Company; it combines a world-class research and development center, ultra-modern pharmaceutical and generics manufacturing facilities, as well as preclinical…
-
MENA region- Pharma Products Exports – Ms. Priyanka Singh Views – Director Taj Pharma Group
Given your expertise in the MEA region, how would you assess the present state of the GCC market and across the wider region? The MENA market faced a slowdown last year, primarily driven by the oil crisis in key countries such as Saudi Arabia, and Algeria, and currency devaluation and economic crises in other countries,…
-
Generics Medicines Initiative Ms. Priyanka Singh Director Taj Pharma
Generics Medicines Initiative: The Beginning: We have seen a lot of vertical integration in health care, typically different health care providers merging, or providers and health plans. But integration of providers into pharmaceutical manufacturing setting aside a little compounding — is pretty unprecedented. Well I would say necessity is the mother of invention, right? This…
-
Compliance and Competitiveness in Indian Pharmaceuticals Industry by Ms. Priyanka Singh Director Taj Pharma Group
Compliance and Competitiveness in Indian Pharmaceuticals Industry: by Ms. Priyanka Singh Director Taj Pharma Group The word “compliance” in India took on a whole new meaning in 2012 when key Indian Pharma Products exports pushed to USA and European Markets without much apprehensions. That new status, known as the “Generalised System” of Preferences plus is…